OptimizeRx Corporation
OPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $380 | $250 | $160 | $90 |
| - Cash | $20 | $17 | $17 | $13 |
| + Debt | $4 | $29 | $33 | $33 |
| Enterprise Value | $364 | $262 | $176 | $109 |
| Revenue | $26 | $29 | $22 | $32 |
| % Growth | -10.7% | 33.1% | -32.1% | – |
| Gross Profit | $18 | $19 | $13 | $22 |
| % Margin | 67.2% | 63.8% | 60.9% | 68.1% |
| EBITDA | $3 | $4 | -$1 | $5 |
| % Margin | 12.1% | 15% | -4.1% | 15.1% |
| Net Income | $1 | $2 | -$2 | -$0 |
| % Margin | 3% | 5.2% | -10% | -0.2% |
| EPS Diluted | 0.04 | 0.081 | -0.12 | -0.004 |
| % Growth | -50.4% | 167.2% | -2,900% | – |
| Operating Cash Flow | $3 | $5 | $4 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $3 | $5 | $4 | $0 |